IRCT20151028024760N5
Not yet recruiting
Phase 2
Evaluation of the effects of supplementation extract prepared from Capparis spinosa on clinical manifestations, para-clinical and immunological factors in patients with refractory rheumatoid arthritis.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Rheumatoid arthritis.
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Resistant rheumatoid arthritis (RA) patients to non\-biological disease\-modifying anti\-rheumatic drugs (DMARDs) Treated RA patients by non\-biological drugs Treated RA patients by Prednisolone, Hydroxychloroquine, Sulfasalazine and Methotrexate Refractory RA patients with no other Rheumatic disorders and inflammatory diseases
Exclusion Criteria
- •Non\-resistant RA patients to non\-biological disease\-modifying anti\-rheumatic drugs (DMARDs)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of AFL footballers.exercise performanceAlternative and Complementary Medicine - Other alternative and complementary medicineMusculoskeletal - Normal musculoskeletal and cartilage development and functionACTRN12622000435785a Trobe University40
Not yet recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of cyclists.ACTRN12622000517774a Trobe University20
Recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of CrossFitters.ACTRN12622000510741a Trobe University20
Not yet recruiting
Phase 2
A comparative study on efficacy of supplementation of iron syrup and iron rich diet in improving the iron status in children aged 6 to 10 years with mild anemia.Health Condition 1: E611- Iron deficiencyCTRI/2024/03/064010nil
Completed
Not Applicable
Supplementation with alpha-tocopherol and ascorbic acid to non-alcoholic fatty liver disease’s statin therapy in meon-alcoholic fatty liver disease (NAFLD)TCTR20180425001Ss. Cyril and Methodius University in Skopje74